FR2705674B1 - Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments. - Google Patents

Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.

Info

Publication number
FR2705674B1
FR2705674B1 FR9306290A FR9306290A FR2705674B1 FR 2705674 B1 FR2705674 B1 FR 2705674B1 FR 9306290 A FR9306290 A FR 9306290A FR 9306290 A FR9306290 A FR 9306290A FR 2705674 B1 FR2705674 B1 FR 2705674B1
Authority
FR
France
Prior art keywords
medicaments
preparation
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306290A
Other languages
English (en)
French (fr)
Other versions
FR2705674A1 (fr
Inventor
Guy Marguerite Marie Gerard Nadler
Marcel Jean-Marie Morvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Laboratoires Pharmaceutiques
Original Assignee
SmithKline Beecham Laboratoires Pharmaceutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9306290A priority Critical patent/FR2705674B1/fr
Application filed by SmithKline Beecham Laboratoires Pharmaceutiques filed Critical SmithKline Beecham Laboratoires Pharmaceutiques
Priority to EP94918376A priority patent/EP0700385A1/en
Priority to AU69717/94A priority patent/AU6971794A/en
Priority to PCT/EP1994/001704 priority patent/WO1994027967A1/en
Priority to ZA943594A priority patent/ZA943594B/xx
Priority to JP7500224A priority patent/JPH09501404A/ja
Priority to TW083104822A priority patent/TW273546B/zh
Publication of FR2705674A1 publication Critical patent/FR2705674A1/fr
Application granted granted Critical
Publication of FR2705674B1 publication Critical patent/FR2705674B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9306290A 1993-05-26 1993-05-26 Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments. Expired - Fee Related FR2705674B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9306290A FR2705674B1 (fr) 1993-05-26 1993-05-26 Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.
AU69717/94A AU6971794A (en) 1993-05-26 1994-05-24 Novel compounds
PCT/EP1994/001704 WO1994027967A1 (en) 1993-05-26 1994-05-24 Novel compounds
ZA943594A ZA943594B (en) 1993-05-26 1994-05-24 Piperidine antiarrhythmics
EP94918376A EP0700385A1 (en) 1993-05-26 1994-05-24 Novel compounds
JP7500224A JPH09501404A (ja) 1993-05-26 1994-05-24 新規化合物
TW083104822A TW273546B (enExample) 1993-05-26 1994-05-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306290A FR2705674B1 (fr) 1993-05-26 1993-05-26 Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.

Publications (2)

Publication Number Publication Date
FR2705674A1 FR2705674A1 (fr) 1994-12-02
FR2705674B1 true FR2705674B1 (fr) 1996-01-05

Family

ID=9447466

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306290A Expired - Fee Related FR2705674B1 (fr) 1993-05-26 1993-05-26 Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.

Country Status (3)

Country Link
FR (1) FR2705674B1 (enExample)
TW (1) TW273546B (enExample)
ZA (1) ZA943594B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100492114C (zh) * 2007-03-28 2009-05-27 友达光电股份有限公司 场序型液晶显示器的驱动方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196210A (en) * 1975-09-23 1980-04-01 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
FR2642069B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
IE903196A1 (en) * 1989-09-05 1991-03-13 Searle & Co Substituted n-benzylpiperidine amides

Also Published As

Publication number Publication date
TW273546B (enExample) 1996-04-01
FR2705674A1 (fr) 1994-12-02
ZA943594B (en) 1995-04-20

Similar Documents

Publication Publication Date Title
FR2707641B1 (fr) Composés de l'imidazol-5-carboxamide, leur procédé de préparation leurs intermédiaires et leur utilisation en thérapeutique.
FR2586683B1 (fr) Nouveaux derives de neothramycine, leur procede de preparation et leur application en tant que medicaments
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2709754B1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
DZ702A1 (fr) Nouveaux dérivés de la carboxymethoxy-7 furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
OA08235A (fr) Composés intermediaires de carbapénem et leur procédé de préparation.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
FR2698095B1 (fr) Utilisation de composés dibenzyléthylène diamino diacétate contre le stress oxydant, compositions pharmaceutiques ou cosmétiques les contenant, composés nouveaux et leur procédé de préparation.
FR2692579B1 (fr) Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2718441B1 (fr) Nouveaux composés de structure benzisoséléna-zoline et -zine, leur procédé de préparation et leurs applications thérapeutiques.
OA06201A (fr) Procédé de préparation de nouveaux composés d'urée et amido .
FR2717802B1 (fr) Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
OA06084A (fr) Nouveaux dérivés de 2-imino-imidazolidine, leur préparation et leur application en tant que médicaments.
BE869275A (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
FR2705674B1 (fr) Nouveaux composés et leur procédé de préparation et leur utilisation en tant que médicaments.
FR2636063B1 (fr) Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
EP0617014A3 (en) Oxime ether compounds, process for their preparation and fungicides containing them.
OA08699A (fr) Aminopropionamides substitués, procédé pour leur préparation, produits les contenat et leur utilisation, ainsi que de nouveaux produit intermediaires pour leur préparation.
FR2710065B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2707986B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
FR2705675B1 (fr) Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
OA08963A (fr) Composés à groupements triazole, utilisation de ceux-ci à titre de fongicides et procédés de préparation.

Legal Events

Date Code Title Description
ST Notification of lapse